Prenatal diagnosis for familial hypercholesterolaemia (FH) was performed by using restriction fragment length polymorphisms (RFLPs) of the LDL receptor gene on chorionic villi DNA taken during the 10th week of pregnancy. Both parents were FH heterozygotes and had previously had a healthy son and an FH homozygous son. Two RFLPs were informative in this family and revealed that the fetus was unaffected by FH. At birth the child was found to have an LDL cholesterol level of 30 mg/dl and a normal LDL receptor activity in cultured umbilical cord fibroblasts. RFLP analysis on chorionic villi DNA is highly recommended for all heterozygous FH couples in whom the LDL receptor gene mutation/s is/are still to be characterized
AIMS: We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and ...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldst...
The first prenatal diagnosis for exclusion of homozygous familial hypercholesterolemia by using the ...
Cardiovascular disease is the leading cause of death worldwide and, like most chronic diseases, it h...
Geisel J, Oette K, Weisshaar B. Diagnosis of Familial Hypercholesterolemia using DNA probes for the ...
Aims We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and c...
The diagnosis of familial hypercholesterolemia (FH) in unselected children is difficult due to the f...
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldst...
Abstract Background and objectives: Familial hypercholesterolemia (FH) is an autosomal disorder char...
Familial Hypercholesterolaemia (FH) is one of the most common monogenic disorders, being caused most...
AIMS: We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and ...
AbstractA cDNA probe for the low density lipoprotein (LDL) receptor gene was used to screen DNA samp...
In most patients with heterozygous familial hypercholesterolaemia (FH) the disorder is caused by a m...
Aim: Familial hypercholesterolaemia (FH) is an autosomal dominant disorder that confers an increased...
AIMS: We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and ...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldst...
The first prenatal diagnosis for exclusion of homozygous familial hypercholesterolemia by using the ...
Cardiovascular disease is the leading cause of death worldwide and, like most chronic diseases, it h...
Geisel J, Oette K, Weisshaar B. Diagnosis of Familial Hypercholesterolemia using DNA probes for the ...
Aims We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and c...
The diagnosis of familial hypercholesterolemia (FH) in unselected children is difficult due to the f...
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldst...
Abstract Background and objectives: Familial hypercholesterolemia (FH) is an autosomal disorder char...
Familial Hypercholesterolaemia (FH) is one of the most common monogenic disorders, being caused most...
AIMS: We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and ...
AbstractA cDNA probe for the low density lipoprotein (LDL) receptor gene was used to screen DNA samp...
In most patients with heterozygous familial hypercholesterolaemia (FH) the disorder is caused by a m...
Aim: Familial hypercholesterolaemia (FH) is an autosomal dominant disorder that confers an increased...
AIMS: We assembled a cohort of patients with familial hypercholesterolaemia (FH) for both basic and ...
Objective: Familial Hypercholesterolemia (FH) is a metabolic disorder inherited as an autosomal domi...
In the early 1980s, the Nobel Prize winning cellular and molecular work of Mike Brown and Joe Goldst...